Anthropic IPO valuation falls to $1.5 trillion as growth slows

By Splitfeed EditorialLast updated Oct 16, 2026, 14:40 UTC

Anthropic entered October 2026 targeting a $2 trillion IPO valuation, supported by revenue of $16.8 billion, a 46 percent year-on-year increase. By mid-October, investor expectations had shifted. Sources cited by multiple outlets indicate the working valuation has fallen to approximately $1.5 trillion, a drop of $500 billion, as investors reassessed whether the growth rate justifies the original price. A sell-off in CoreWeave shares added pressure, with analysts noting it is reshaping how markets are pricing both Anthropic and OpenAI ahead of their respective offerings. At least one analyst, quoted by The Next Web, labeled the Anthropic IPO the most ridiculous of 2026.

The central tension here is the gap between absolute scale and growth trajectory. A 46 percent revenue increase is large by most standards, but for a company seeking a valuation in the trillions, investors are scrutinizing whether that pace is decelerating fast enough to matter. The CoreWeave effect adds a structural dimension: when a major AI infrastructure company sees its shares sold off, it signals that broader market confidence in AI-sector valuations is under pressure, not just Anthropic's specific story. That makes the $1.5 trillion figure not simply a negotiation point but a possible indicator of sentiment across the AI investment landscape.

None of the three camps, pro-AI, anti-AI, or middle ground, have published specific reactions to this story. Pro-AI voices would typically point to the $16.8 billion revenue figure as evidence of real commercial adoption, arguing that even a $1.5 trillion valuation reflects genuine market leadership rather than hype. Anti-AI commentators would likely treat the valuation correction as confirmation that AI company financials have been inflated by speculative enthusiasm rather than sustainable fundamentals, and would cite the analyst's sharp language as a sign that scrutiny is finally arriving. A middle-ground position would probably focus on the distinction between a company that is genuinely growing and one that can justify a multiple this large, framing the pullback as a healthy recalibration rather than either a vindication or a crisis.

The IPO filing itself, and the final offer price set when bookbuilding closes, will be the clearest test of where institutional demand actually lands. If the company prices near $1.5 trillion and the shares hold, it would support the growth story. A further reduction, or a weak debut, would strengthen the bear case that AI valuations broadly ran ahead of what the underlying numbers can support.